Woodline Partners LP Reata Pharmaceuticals Inc Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$79.22 - $105.37 $16.2 Million - $21.6 Million
205,108 New
205,108 $20.9 Million
Q2 2021

Aug 16, 2021
SELL
$78.27 - $151.29 $400,820 - $774,756
-5,121 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$94.25 - $132.81 $6.41 Million - $9.03 Million
-67,976 Reduced 92.99%
5,121 $511,000
Q4 2020

Feb 16, 2021
BUY
$102.03 - $184.62 $7.46 Million - $13.5 Million
73,097 New
73,097 $9.04 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email